Hong Kong scrambles for talent in battle for Nasdaq's biotech crown
HONG KONG (Reuters) - When Hong Kong unveiled plans last year to encourage biotech companies to list in the city by loosening listing rules, the financial industry and investors cheered.
from Reuters: Health News https://reut.rs/2FrCsNh
http://bit.ly/2zwRqiM
April 29, 2018
|
Labels:
health,
Reuters: Health News
|
This entry was posted on April 29, 2018
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.